A reading guide to the people behind the ideas

The report brings together people who work in different settings and do not necessarily share a theory. Some contribute anatomical observations, some test clinical treatments, and others offer a practice or a hypothesis. Their inclusion does not imply that they endorse Functional Fascia, its products or this synthesis.

This directory introduces their role through a specific publication or first-party description. It is a reading guide, not a ranking of authorities. Follow an idea to its source and ask what the source can actually establish.

Carla Stecco: gliding interfaces and their cells

Stecco’s anatomical work gives the report a concrete starting point for discussing fascia beyond collagen. The fasciacyte paper focuses on cells associated with HA production and gliding regulation. 1 Start with hyaluronan and gliding to see how that observation differs from a treatment claim.

Ginevra Liptan and Daniel Clauw: two parts of the pain question

Liptan’s fascia hypothesis asks about a peripheral contributor to fibromyalgia; Clauw’s clinical review explains a pain-processing framework. 2 3 Reading them together helps avoid forcing a choice between tissue input and altered processing. The proposed integration belongs to this report, not to a joint theory issued by the two authors.

Anne Louise Oaklander and Andreas Goebel: peripheral mechanisms

Oaklander’s small-fiber investigation and Goebel’s antibody-transfer work approach peripheral contributions through different experiments. 4 5 Neither makes a symptom checklist into a diagnosis. The nerve and immune article explains why these findings encourage subgroup research.

Amir Minerbi and Arkady Khoutorsky: the microbiome–pain question

Their work connects microbial communities to experimental pain research and early human investigation. 6 Begin with the gut–pain connection for the difference between an animal transfer experiment, an uncontrolled human study and a tested clinical treatment.

Mark Lumley and Howard Schubiner: emotional processing

The EAET fibromyalgia trial is a useful entry into their work because it permits a close comparison of interventions and outcomes. 7 Their relevance here is a testable psychological treatment approach, not a claim that every person’s illness has an emotional origin.

Alan Gordon, Yoni Ashar and Tor Wager: pain reprocessing

The chronic-back-pain PRT trial is the main starting point. 8 Its findings are relevant to ideas about interpretation and threat, with a population boundary that matters. EAET and PRT explained separates the direct fibromyalgia evidence from this adjacent-condition research.

Jessica Eccles and Hugo Critchley: connective tissue and bodily regulation

Their work on hypermobility and overlapping conditions invites a closer look at connective-tissue traits and bodily signaling. 9 It is particularly relevant when “tightness” coexists with excess range or difficulty controlling a task. Read hypermobility and stability before assuming more flexibility is the goal.

Mario Cordero: energy-related clinical questions

Cordero’s CoQ10 work connects a proposed biological target with an early clinical experiment. 10 The energy article places it alongside a useful counterexample: a trial can improve a muscle measure without improving the full symptom pattern.

Chenchen Wang and Kaisa Mannerkorpi: movement tested in people

Wang’s tai chi comparison and resistance-exercise research involving Mannerkorpi supply direct clinical studies of movement approaches. 11 12 Their value is in the defined programs and outcomes, not in proving every biomechanical explanation used by movement practitioners.

Theoharis Theoharides and Ethan Russo: mechanisms to investigate

Theoharides’ work discussed here concerns inflammatory mediators and a proposed mast-cell role. Russo’s contribution is the endocannabinoid-deficiency hypothesis. 13 14 These are different lines of inquiry. Neither should become a universal diagnosis because its explanation feels familiar.

Kevin Boehnke and Jacob Aday: early psychedelic clinical research

Their fibromyalgia pilot supplies a direct but very small clinical starting point. 15 Read plasticity and psychedelics for its design, the role of supervised support, and why it cannot validate a home microdosing regimen.

Brooke McPoyle and Paul Stamets: practitioner proposals and combinations

McPoyle’s Fascia Flow is referenced as a practitioner approach to fascia exploration. Its course page is a source for what is offered, not independent effectiveness evidence. 16 Stamets is referenced for the combination proposal discussed alongside observational microdosing research. 17 A proposed combination needs its own evaluation; familiarity with its individual components cannot establish the blend’s clinical benefit.

Functional Patterns: a movement-system reference

Functional Patterns, founded by Naudi Aguilar, supplies a branded perspective on gait, posture and coordinated movement. Its own material explains the approach. 18 The movement article examines how to evaluate such a system while keeping self-description separate from independent evidence.

How to read across these perspectives

Begin with a question, then choose the paper or approach that actually addresses it. An anatomical researcher, a clinician running a trial and a practitioner teaching a course can each offer something different. Agreement at the level of a theme does not make their evidence interchangeable.

The report’s synthesis is most useful when these differences remain visible. Readers can take an idea seriously, inspect its limits and decide which question deserves closer attention next.

Educational publication, not individualized medical advice. Functional Fascia also sells supplements; the studies here did not test our products. Editorial and commercial context · Suggest a correction